Head-to-head · WeighScore
Bon Health vs Piper
By GLP-1 ScorecardUpdated
Score comparison
Piper has the higher recorded score — 81.9/100 to 69.7/100.
Piper grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Now branded Polly; compare its complete payment schedule.
Before you choose
Before comparing the headline prices, the Bon Health review and the Piper review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Bon Health vs TOM Weight Loss and Brello Health vs Piper compare each of them with another graded program, and the list of alternatives to Bon Health ranks the programs closest to Bon Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Belle Health review covers one graded close to these two, at 73.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Bon Health | Piper |
|---|---|---|
| WeighScore | 69.7/100 | 81.9/100 |
| Grade | C | B− |
| Site position | #128 | #29 |
| Semaglutide | $220/mo advertised on monthly billing; $1,140 billed yearly at the $95/mo equivalent | $179 monthly; $135/month equivalent with six months prepaid. |
| Tirzepatide | $285/mo advertised on monthly billing; $1,620 billed yearly at the $135/mo equivalent | $279/mo month-to-month; $199/mo equivalent requires six months and $1,194 prepaid. |
| Coverage | Confirm eligibility for the selected treatment | All-state access claimed; confirm individual eligibility. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Product pages show separate monthly, quarterly, six-month and annual totals
- Product pages advertise no membership fee
- The site identifies its merchant of record
What to consider
- The lowest monthly equivalents require annual billing
- The public site terms do not settle the refund on an unused prepaid balance
- Confirm the assigned pharmacy and selected invoice before paying
Strengths
- Price FAQs distinguish monthly and prepaid plans.
- All-state access is advertised; individual eligibility needs confirmation.
- Advertises compounded injectable semaglutide and tirzepatide.
What to consider
- Assigned clinicians and dispensing facilities need confirmation.
- Refund cutoffs differ across public pages.
- Confirm the selected monitoring, billing and supply schedule.
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.